The city of Jackson, Mississippi, currently has 1 active clinical trials seeking participants for Ulcerative Colitis research studies.
Safety and Efficacy of Efavaleukin Alfa in Participants With Moderately to Severely Active Ulcerative Colitis
The main purpose of this study is to evaluate the effect of efavaleukin alfa on induction of clinical remission in participants with moderately to severely active ulcerative colitis (UC). Participants will be randomized to receive 1 of 3 efavaleukin alfa doses or placebo during a 12-week induction period. Participants who complete the 12-week induction period will have the option to enter an exploratory long-term treatment period for up to 40 weeks (total of up to 52 weeks of treatment) if, in... Read More
Between 18 years and 80 years
Trial Updated:
Locations: Southern Therapy and Advanced Research LLC - Jackson, Jackson, Mississippi
Conditions: Ulcerative Colitis